0001725160-23-000200.txt : 20231113 0001725160-23-000200.hdr.sgml : 20231113 20231113172408 ACCESSION NUMBER: 0001725160-23-000200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231113 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blackwell Kimberly CENTRAL INDEX KEY: 0001816465 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 231400164 MAIL ADDRESS: STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC STREET 2: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823607803 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 4 1 wk-form4_1699914229.xml FORM 4 X0508 4 2023-11-13 0 0001725160 Zentalis Pharmaceuticals, Inc. ZNTL 0001816465 Blackwell Kimberly C/O ZENTALIS PHARMACEUTICALS, INC. 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-11-13 4 P 0 5000 10.2896 A 254800 D By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kimberly Blackwell 2023-11-13